Showing 12 of 13059 posts
Chinese state media on Thursday questioned the ability of Futu and Tiger Brokers to meet requirements of the country’s strict new data protection law. As a result, the two brokers’ shares decreased sharply before markets opened in the U.S.
Carl Pei, CEO of Nothing and Co-Founder of OnePlus, announced on October 18 that the price of the Ear (1) wireless headphones under the Nothing brand will be increased from $99 to $149 from October 26 due to rising costs.
Zhu Jiang, a former senior executive of car companies such as BMW, Lexus, NIO and Ford, has confirmed his appointment as vice president of Jidu Automobile.
Chinese AI firm 4Paradigm updated its prospectus on Wednesday for a public listing to the stock market's main board, with Goldman Sachs and CICC serving as co-sponsors.
Huawei announced on Wednesday that it had reached a patent licence agreement with Japan-based Buffalo, a provider of networking, storage and memory products.
Recent weeks have seen soaring COVID-19 cases across China, pushing many people to various domestic health platforms in an attempt to purchase coveted antiviral medication and fever-reduction pills.
Lu Jian, Vice President of LinkedIn Global and President of LinkedIn China, described the reasons behind the company's strategic adjustment and its future on Wednesday.
Shanghai-based HP Micro Semiconductor Technology Co., Ltd. has successfully completed the first phase of verification for its high-performance HPM6E00 chip, the first in China to feature an EtherCAT Slave Controller (ESC) authorized by Germany's Beckhoff.
When the Canadian police in December 2018 abruptly detained Meng Wanzhou, Huawei’s CFO, China-Canada relations were inevitably slipping into an awkward position.
Domestic authorities contend that the move is designed to put an end to the 'chaos' of online fan clubs, the Securities Times reported on Thursday.
Xiaomi announced the release of Mi MIX Alpha concept smartphone and it’s the most expensive phone of Xiaomi so far, with a price tag of $2800.
Yaoshibang, a Chinese pharmaceutical distribution platform, submitted an application on Tuesday for a public listing to the Hong Kong Stock Exchange (HKEx), with Goldman Sachs and CICC named as co-sponsors.